Empower Advisory Group LLC Increases Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• Empower Advisory Group LLC increased its holdings in Intuitive Surgical, Inc. by 81.1%, owning 3,016 shares valued at approximately $1.49 million as of the latest SEC filing.
• Several institutional investors also made significant moves, with New Age Alpha Advisors LLC increasing its stake by 221.4% to 6,762 shares valued at over $3.34 million.
• Analysts maintain a Moderate Buy consensus on Intuitive Surgical, with target prices being raised, including UBS Group lifting its price target from $547 to $585.

Empower Advisory Group LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 81.1% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,016 shares of the medical equipment provider's stock after buying an additional 1,351 shares during the quarter. Empower Advisory Group LLC's holdings in Intuitive Surgical were worth $1,494,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Advyzon Investment Management LLC purchased a new stake in Intuitive Surgical in the 1st quarter valued at about $561,000. New Age Alpha Advisors LLC grew its holdings in shares of Intuitive Surgical by 221.4% in the first quarter. New Age Alpha Advisors LLC now owns 6,762 shares of the medical equipment provider's stock valued at $3,349,000 after acquiring an additional 4,658 shares in the last quarter. Wills Financial Group LLC purchased a new stake in shares of Intuitive Surgical during the first quarter valued at approximately $223,000. Geneva Capital Management LLC lifted its holdings in Intuitive Surgical by 15.0% during the first quarter. Geneva Capital Management LLC now owns 4,251 shares of the medical equipment provider's stock worth $2,105,000 after acquiring an additional 553 shares during the period. Finally, IPG Investment Advisors LLC boosted its position in Intuitive Surgical by 3.9% in the first quarter. IPG Investment Advisors LLC now owns 2,880 shares of the medical equipment provider's stock worth $1,426,000 after purchasing an additional 109 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have recently issued reports on ISRG. Truist Financial raised their target price on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. BTIG Research raised their price objective on shares of Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a report on Wednesday, July 23rd. Evercore ISI boosted their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research note on Tuesday, July 8th. Piper Sandler reissued an "overweight" rating and set a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Finally, UBS Group lifted their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a report on Wednesday, July 23rd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company's stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Trading Down 1.3%

Shares of Intuitive Surgical stock opened at $477.00 on Wednesday. The company's 50-day moving average price is $521.43 and its 200-day moving average price is $531.52. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The company has a market cap of $170.99 billion, a price-to-earnings ratio of 66.53, a PEG ratio of 5.07 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. During the same period in the prior year, the company posted $1.78 EPS. The business's revenue for the quarter was up 21.4% compared to the same quarter last year. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In related news, insider Gary S. Guthart sold 7,893 shares of Intuitive Surgical stock in a transaction on Monday, July 28th. The stock was sold at an average price of $498.64, for a total transaction of $3,935,765.52. Following the completion of the sale, the insider owned 13,187 shares of the company's stock, valued at approximately $6,575,565.68. This trade represents a 37.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Mark Brosius sold 216 shares of the business's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the transaction, the senior vice president owned 907 shares of the company's stock, valued at approximately $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 15,903 shares of company stock valued at $7,932,778. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.